Brief: Klaria Signs License Agreement For Sumatriptan Alginate Film In Europe With CNX Therapeutics
Jan 10 (Reuters) - Klaria Pharma Holding AB (publ)
KLAR.ST :
* SIGNS LICENSE AGREEMENT FOR SUMATRIPTAN ALGINATE FILM IN
EUROPE
WITH CNX THERAPEUTICS
* AGREEMENT GIVES CO UP-FRONT PAYMENT OF EUR750,000,
MILESTONE
PAYMENTS OF APPROX. EUR500,000 - 1,250,00
Source text: ID:nWkr2gSkkW
Further company coverage: KLAR.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement